A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActiveTM) for COVID-19 Patients.
Muhammed MajeedNagabhushanam KalyanamKalpesh ShahLakshmi A MundkurPublished in: Evidence-based complementary and alternative medicine : eCAM (2021)
The study results suggest that ImmuActive could be a beneficial and safe adjunct treatment for effectively managing COVID-19 infection symptoms.